2025-04-24T11:54:35-05:00 2024-06-30 872525370 CITRIN COOPERMAN ADVISORS LLC 11400 WEST OLYMPIC BLVD 350 LOS ANGELES CA 90064 990 2023-07-01 223307141 THE PITUITARY SOCIETY INC PITU 3109889486 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 DR SHLOMO MELMED SECRETARY-TREASURER 3109889486 2025-04-14 1 1 SHEILA MOGHIMI-KAMRAN P00170368 3104778355 2025-04-14 2023 2025-03-06 01:10:19Z DR SHLOMO MELMED 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 551129 0 X N/A X 1994 DE TO PROVIDE SCIENTISTS, CLINICIANS AND TRAINEES WITH THE MOST UP-TO-DATE, RELIABLE RESEARCH AND EDUCATION ON THE BIOLOGY OF THE PITUITARY GLAND AND THE CAUSES, DIAGNOSIS AND TREATMENT OF PITUITARY GLAND RELATED DISEASES, IN ORDER TO IMPROVE PATIENT CARE AND TO PROVIDE A UNIQUELY INTERNATIONAL FORUM FOR PROFESSIONAL GROWTH AND SCIENTIFIC EXCHANGE. 14 14 0 63 0 0 433264 413854 327460 66725 27475 63243 9896 7307 798095 551129 0 0 0 0 0 0 0 0 0 549749 488822 549749 488822 248346 62307 2298432 2128717 240767 8745 2057665 2119972 X OUR MISSION IS TO PROVIDE SCIENTISTS, CLINICIANS AND TRAINEES WITH THE MOST UP-TO-DATE, RELIABLE RESEARCH AND EDUCATION ON THE BIOLOGY OF THE PITUITARY GLAND AND THE CAUSES, DIAGNOSIS AND TREATMENT OF PITUITARY GLAND RELATED DISEASES, IN ORDER TO IMPROVE PATIENT CARE AND TO PROVIDE A UNIQUELY INTERNATIONAL FORUM FOR PROFESSIONAL GROWTH AND SCIENTIFIC EXCHANGE. 0 0 240971 66725 IN JUNE, 2023, WE HELD OUR 18TH INTERNATIONAL PITUITARY CONGRESS IN CHICAGO, IL. TWO HUNDRED AND NINETY-THREE ATTENDEES FROM AROUND THE WORLD ATTENDED THE TWO-AND-A-HALF-DAY CONGRESS. THE BIENNIAL INTERNATIONAL PITUITARY CONGRESS IS AN EDUCATIONAL OPPORTUNITY FOR PITUITARY SPECIALISTS, NEUROENDOCRINOLOGISTS, AND NEUROSURGEONS TO REVIEW THE LATEST RESEARCH AND CLINICAL HIGHLIGHTS REGARDING PATIENTS WITH PITUITARY DISORDERS. SPECIFICALLY, THERE IS A CRITICAL NEED TO BRING TOGETHER AN INTERNATIONAL COMMUNITY OF LABORATORY RESEARCHERS, TRANSLATIONAL AND CLINICIAN SCIENTISTS, AND CLINICIANS TO CONSIDER MAJOR ADVANCES IN PITUITARY DISORDERS AND TIE THEM TO CLINICAL CARE. THIS SCIENTIFIC PROGRAM HIGHLIGHTS KEY ADVANCES IN UNDERSTANDING BASIC PITUITARY AND NEUROENDOCRINE REGULATION AND REVIEWS THESE FINDINGS IN CONJUNCTION WITH STATE-OF-THE-ART MANAGEMENT OF PATIENTS WITH PITUITARY TUMORS, PITUITARY DEFICIENCY STATES AND NEUROENDOCRINE DISORDERS. 15000 CONSENSUS STATEMENT PUBLISHED IN NATURE REVIEWS ENDOCRINOLOGY IN SEPTEMBER 2023 ON DIAGNOSIS AND MANAGEMENT OF PROLACTIN-SECRETING PITUITARY ADENOMAS: A PITUITARY SOCIETY INTERNATIONAL CONSENSUS STATEMENT. 14740 PRECEPTORSHIP COURSE FOR FELLOWS-IN-TRAINING HELD IN FEBRUARY 2024. THIS COURSE, THE SIXTH SINCE ITS INCEPTION, CONSISTED OF TWO WEBINARS HELD ON FEBRUARY 5 AND 7, 2024. THE COURSE WAS ATTENDED BY APPROXIMATELY 225 FELLOWS-IN-TRAINING. FELLOWS WERE REQUIRED TO SUBMIT AN INTERESTING PITUITARY CASE IN ORDER TO ATTEND THE COURSE. CASES WERE REVIEWED BY FACULTY AND FOUR-TO-SIX WERE SELECTED TO BE PRESENTED BY THE FELLOWS DURING THE CASE DISCUSSION. FACULTY RECORDED PRESENTATIONS ON ALL PITUITARY PATHOLOGY WERE VIEWED BY THE FELLOWS PRIOR TO THE LIVE WEBINARS TO ALLOW FOR MORE INTERACTIVE LEARNING.OVER THE LAST DECADE, MANY ENDOCRINOLOGY FELLOWSHIP PROGRAMS REDUCED THE TRAINING REQUIREMENTS FROM 3 YEARS TO 2 YEARS TO BE ELIGIBLE FOR BOARD CERTIFICATION. IN PARALLEL, DIABETES AND OBESITY INCIDENCE AND PREVALENCE INCREASED SIGNIFICANTLY, LIMITING CLINICAL EXPERIENCES ON OTHER RARER, NEVERTHELESS SEVERE AND POTENTIALLY LETHAL DISEASES, SUCH AS PITUITARY DISORDERS. THEREFORE, THIS COURSE TAUGHT BY LEADING INTERNATIONAL EXPERTS, ADDRESSED SOME OF THESE ISSUES BY REVIEWING FOR TRAINEES ADVANCEMENTS IN DIAGNOSIS AND TREATMENT OF HYPOPITUITARISM, GROWTH HORMONE DEFICIENCY, CUSHING'S SYNDROME AND ACROMEGALY AS WELL AS MANAGEMENT OF PITUITARY DISEASE IN THE POST-COVID ERA. 7870 ACROMEGALY & CUSHING'S SYNDROME: STRIVING FOR EXCELLENCE WEBINAR WAS HELD NOVEMBER 27, 2023. THE MISSION OF THIS PROGRAM WAS TO UPDATE GLOBAL ACROMEGALY AND CUSHING'S SYNDROME APPROACHES, THEREBY ALLOWING CLINICIANS WORLDWIDE TO IMPROVE THEIR PATIENTS' QUALITY OF LIFE, MORBIDITY AND MORTALITY. THE STRUCTURE OF THE MEETING UTILIZED A WORKSHOP FORMAT WITH PREVIOUS COMMUNICATIONS BY VIRTUAL MEETINGS AND EMAIL BETWEEN SPEAKERS AND CHAIRS, PANELISTS/STEERING COMMITTEE. INVITED FACULTY AND SPEAKER PARTICIPANTS WERE INTERNATIONAL EXPERTS IN THE FIELD OF ACROMEGALY AND CUSHING'S SYNDROME FROM EUROPE, NORTH AND SOUTH AMERICA AND AUSTRALIA. DURING THE WEBINAR, THESE EXPERTS DISCUSSED "STATE OF THE ART" ISSUES AND UPDATES FOR GENDER AND AGE PRESENTATION, SINGLE AND COMBINATION REGIMENS IN THE MEDICAL TREATMENT OF ACROMEGALY, SELF-ADMINISTRATION OF LONG-ACTING INJECTABLE SOMATOSTATIN RECEPTOR LIGANDS, SURGERY, AND PREDICTORS OF OUTCOME TO MEDICAL TREATMENT WITH THE GOAL OF IMPROVING PATIENTS' OUTCOMES AND CHANGES IN CARE DELIVERY. DIAGNOSIS OF CUSHING'S SYNDROME REMAINS COMPLEX. CYCLIC CUSHING'S SEEMS TO BE MORE FREQUENTLY SEEN THAN PREVIOUSLY THOUGHT. ALSO, ADVANCES IN IMAGING CAN FIND MORE PITUITARY ADENOMAS, BUT THEIR ROLE ON INCREASED REMISSION POST-SURGERY IS NOT WELL DEFINED. NOVEL MEDICATIONS FOR CUSHING'S SYNDROME HAVE BEEN DEVELOPED AND APPROVED RECENTLY AND EXPERTS WILL DISCUSS LONG TERM FOLLOW-UP. ADDITIONALLY, THE PITUITARY SOCIETY GUIDELINE CONSENSUS ON DIAGNOSIS AND MANAGEMENT OF CUSHING'S DISEASE: A GUIDELINE UPDATE, WILL BE REVIEWED AND DISCUSSED. 5565 OTHER MISCELLANEOUS PROGRAM EXPENSES 13435 284146 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 14 14 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 CA X DR SHLOMO MELMED 3109889486 8700 BEVERLY BLVD 2051 LOS ANGELES CA 90048 X LAURENCE KATZNELSON MD PRESIDENT 6.00 X X 0 0 0 SHLOMO MELMED MB CHB MACP FRCP SECRETARY-TREASURER 6.00 X X 0 0 0 KEN HO MD CO-DIRECTOR, PROGRAMS 0.30 X X 0 0 0 MARIA FLESERIU MD FACE CO-DIRECTOR, PROGRAMS 0.30 X X 0 0 0 FELIPE F CASANUEVA MD PHD INTERNATIONAL RELATIONS 0.30 X X 0 0 0 ANDREA GIUSTINA MD EDITOR, PITUITARY 0.30 X X 0 0 0 NIENKE BIERMASZ MD PHD DIRECTOR 0.30 X 0 0 0 ELIZA GEERMD DIRECTOR 0.30 X 0 0 0 LISA NACHTIGALL MD DIRECTOR 0.30 X 0 0 0 ROSARIO PIVONELLO MD PHD DIRECTOR 0.30 X 0 0 0 YUTAKA TAKAHASHI MD PHD DIRECTOR 0.30 X 0 0 0 GUDMUNDUR JOHANNSSON MD PHD DIRECTOR 0.30 X 0 0 0 ANN MCCORMACK MD DIRECTOR 0.30 X 0 0 0 KEVIN YUEN MD DIRECTOR 0.30 X 0 0 0 0 0 0 0 0 0 0 0 21575 392279 413854 MEETING REGISTRATION 611430 51725 51725 PROGRAM EXHIBITOR PAYM 900099 15000 15000 66725 63243 63243 CREDIT CARD REWARDS/DI 900099 7307 7307 7307 551129 66725 0 70550 7037 7037 25000 15000 10000 220 220 43059 43059 7143 7143 9053 5565 3488 274119 241076 33043 14568 14568 SHARED EXPENSES - CEDAR 101118 15000 86118 RECOGNITION AWARDS 7505 7505 488822 284146 204676 0 432890 18847 1849109 1992848 6433 107022 10000 10000 2298432 2128717 240767 8745 240767 8745 X 2057665 2119972 2057665 2119972 2298432 2128717 62307 0 X 0 0 0 X 92756 1464 22450 433264 413854 963788 348673 723830 262450 327460 66725 1729138 441429 725294 284900 760724 480579 2692926 0 43076 314830 357906 43076 314830 357906 2335020 6008 338 137 27475 63243 97201 6008 338 137 27475 63243 97201 2092 9896 7306 19294 447437 725632 287129 798095 551128 2809421 0.83110 0.97250 0.03460 0.01050 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION PROVIDES EACH MEMBER OF ITS GOVERNING BODY WITH THE FORM 990, BEFORE IT IS FILED, FOR THEIR REVIEW AND ULTIMATE APPROVAL FOR FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION REQUIRES AN ANNUAL RE-EXAMINATION OF CONFLICT OF INTEREST, WHEREBY THE BOARD OF DIRECTORS AND ALL OFFICERS NEED TO SIGN A FORM VERIFIYING THAT THERE ARE NO CONFLICTS OR IF THERE ARE, DISCLOSING THEM. THE ORGANIZATION THEN MONITORS THE DECISION MAKING PROCESS TO ENSURE IT IS NOT TAINTED BY POTENTIAL CONFLICT. FORM 990, PART VI, SECTION C, LINE 19 ALL GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE HELD BY THE DIRECTOR AND ARE AVAILABLE FOR THE PUBLIC TO REVIEW AT ANY TIME.